Summit Partners Public Asset Management, LLC Moderna, Inc. Transaction History
Summit Partners Public Asset Management, LLC
- $4.13 Billion
- Q4 2024
A detailed history of Summit Partners Public Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 30,000 shares of MRNA stock, worth $1.07 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$1.07 Million% of portfolio
0.18%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRNA
# of Institutions
925Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.44 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.38 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$910 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$626 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$260 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...